Show
blank_164_164
European Chips Act and Upcoming EU Semiconductor Projects for 2023-2024
Europe has a vibrant semiconductor manufacturing industry with a significant presence from most of the key providers.
blank_164_164
Supporting Cell Gene Therapy Through Multimodal Flexible Facilities
Cell and gene therapies (C&GT) have unique needs in manufacturing suites that differ from those for classic product biopharmaceuticals. Facilities must be created with flexibility in mind, able to run multiple products and production types to remain viable.
blank_164_164
Arcadis Completes the Acquisition of DPS Group Creating a Leading Position in the Life Sciences and Semiconductor Manufacturing Market
DPS’s high growth and resilient Life Sciences and Semiconductor manufacturing expertise will become part of Arcadis’ Places Global Business Area (GBA) • Arcadis adds an extra 2,850 talented employees to its growing business
blank_164_164
Project Operations Growth in Switzerland
The DPS Group Visp, Switzerland, project operations office opened in April 2020. Initially, this supported our work with our local client Lonza.
blank_164_164
2022 ISPE Annual Meeting
Emerging into my new role as Vice President of Business Development at DPS Group’s Kansas City office, I had the opportunity to participate in the 2022 ISPE Annual Meeting in Orlando, Florida.
blank_164_164
Global Semiconductor Construction Resource Requirements
DPS Group’s Richard Casey shares his thoughts on the growth and requirements in the semiconductor construction industry